Drug Database
Back to search

Netherlands· NL-242ed9364c22

Tenofoviralafenamide Devatis 25 mg, filmomhulde tabletten

A tenofovir alafenamide product containing tenofoviralafenamidemonofumaraat, registered in Netherlands by Devatis GmbH. The same ATC class is registered in 14 of our 19 countries.

ATC J05AF13

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedTenofoviralafenamide Devatis 25 mg, f…ATCJ05AF13REGISTER NO.NL-242ed9364c22PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tenofoviralafenamidemonofumaraatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tenofovir alafenamide is registered in 14 of 19 countries.

Countries holding a registration under ATC J05AF13 (tenofovir alafenamide), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search tenofovir alafenamide products by name

Tenofovir alafenamide · ATC J05AF13

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tenofovir alafenamide costs, country by country.

Normalised to the WHO defined daily dose (25 mg), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Tenofovir alafenamide · price per daily dose (25 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$20.29
  • IT Italy$18.37
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TENOFOVIRALAFENAMIDEMONOFUMARAAT
Manufacturer
Devatis GmbH
Country
Netherlands (NL)
ATC code
J05AF13
ATC class
Tenofovir alafenamide
Defined daily dose
25 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    134865

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tenofovir alafenamide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tenofovir alafenamide products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Germany · Tenofoviralafenamid Devatis
  • Iceland · Vemlidy
  • Liechtenstein · Vemlidy
  • Norway · Vemlidy
  • Portugal · Tenofovir Alafenamida Humanis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9c4561f6-04f0-4a65-a05a-9bb533c8dc2c
GET /v1/drugs/9c4561f6-04f0-4a65-a05a-9bb533c8dc2c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h134865_smpc.pdf",
  "strength": null,
  "atc_label": "Tenofovir alafenamide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg134865",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "IJZEROXIDE GEEL (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POLYVINYLALCOHOL (E 1203)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "TENOFOVIRALAFENAMIDEMONOFUMARAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h134865.pdf",
  "authorised_at": "2026/03/24",
  "procedure_number": "NL/H/6258/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "134865",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about tenofovir alafenamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console